» Articles » PMID: 1549120

Dominant Negative Mutants of Transforming Growth Factor-beta 1 Inhibit the Secretion of Different Transforming Growth Factor-beta Isoforms

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1992 Apr 1
PMID 1549120
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-beta (TGF-beta) is a secreted polypeptide factor that is thought to play a major role in the regulation of proliferation of many cell types and various differentiation processes. Several related isoforms have been structurally characterized, three of which, TGF-beta 1, -beta 2, and -beta 3, have been detected in mammalian cells and tissues. Each TGF-beta form is a homodimer of a 112-amino-acid polypeptide which is encoded as a larger polypeptide precursor. We have introduced several mutations in the TGF-beta 1 precursor domain, resulting in an inhibition of TGF-beta 1 secretion. Coexpression of these mutants with wild-type TGF-beta 1, -beta 2, and -beta 3 results in a competitive and specific inhibition of the secretion of different TFG-beta forms, indicating that these mutated versions act as dominant negative mutants for TGF-beta secretion. Overexpression of dominant negative mutants can thus be used to abolish endogenous secretion of TGF-beta and structurally related family members, both in vitro and in vivo, and to probe in this way the physiological functions of the members of the TGF-beta superfamily.

Citing Articles

Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation.

Galeone A, Adams J, Matsuda S, Presa M, Pandey A, Han S Elife. 2020; 9.

PMID: 32720893 PMC: 7394544. DOI: 10.7554/eLife.55596.


Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer.

Zhang J, Ten Dijke P, Wuhrer M, Zhang T Protein Cell. 2020; 12(2):89-106.

PMID: 32583064 PMC: 7862465. DOI: 10.1007/s13238-020-00741-7.


Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences.

Anderson E, Wharton K J Biol Chem. 2017; 292(47):19160-19178.

PMID: 28924042 PMC: 5702660. DOI: 10.1074/jbc.M117.793513.


A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Akiyama T, Marques G, Wharton K Sci Signal. 2012; 5(218):ra28.

PMID: 22472650 PMC: 3699424. DOI: 10.1126/scisignal.2002549.


Biological Significance of Local TGF-β Activation in Liver Diseases.

Hayashi H, Sakai T Front Physiol. 2012; 3:12.

PMID: 22363291 PMC: 3277268. DOI: 10.3389/fphys.2012.00012.


References
1.
Beckmann R, Mizzen L, Welch W . Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science. 1990; 248(4957):850-4. DOI: 10.1126/science.2188360. View

2.
Pelton R, Hogan B, Miller D, Moses H . Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol. 1990; 141(2):456-60. DOI: 10.1016/0012-1606(90)90401-4. View

3.
Ozkaynak E, Rueger D, Drier E, Corbett C, Ridge R, Sampath T . OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 1990; 9(7):2085-93. PMC: 551926. DOI: 10.1002/j.1460-2075.1990.tb07376.x. View

4.
Mason A, Hayflick J, Ling N, Esch F, Ueno N, Ying S . Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature. 1985; 318(6047):659-63. DOI: 10.1038/318659a0. View

5.
Graycar J, Miller D, Arrick B, Lyons R, Moses H, Derynck R . Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol. 1989; 3(12):1977-86. DOI: 10.1210/mend-3-12-1977. View